MyndTec Inc. announced that it has received from the U.S. Food and Drug Administration (the "FDA") 510(k) clearance for MyndMove 2.0, its second generation neuromodulation MyndMove System. The MyndMove System is a touch screen, eight-channel neuromodulation device that delivers short electrical pulses to stimulate muscle contractions and enhance motor recovery following stroke or spinal cord injury. The MyndMove System includes a stimulator unit, electrodes, hand and foot switches, an optional cart, and integrated software that allows the user to choose from a number of pre-programmed stimulation protocols, to customize the stimulation intensities for each patient and document the treatments provided.